We are building a range of high-quality cannabinoid products that patients and consumers can trust, that are well-characterized and enable dose titration, with the aim of improving options for physicians, patients, and consumers.
We publish our science in peer-reviewed journals and our ambition is to develop innovative products with safe and effective delivery systems for targeted populations and outcomes.
Useful resources
01
We work with industry partners, academic institutions, and regulatory bodies worldwide to improve evidence-based frameworks for cannabinoid product quality, safety, and predictability.
Our team of experts and scientists participates in working groups and committees, such as the ASTM International #D37 Committee on Cannabis.
We believe that robust, science-backed regulations not only protect patients and consumers but also create an environment where responsible innovation can flourish.
02
We promote open and accessible information and resources.
We support and provide structured medical education programs for our stakeholders.
Quality
From botany to bioavailability, through product purity to stability, to dose control and responsible commercialization. Every step is carefully managed and monitored.
Testimonials
